Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease Reply

被引：0
|
作者：
Yang, Daizhi [1 ,2 ]
Yan, Jinhua [1 ,2 ]
Weng, Jianping [2 ,3 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol, Guangzhou, Peoples R China
[2] Guangdong Prov Key Lab Diabetol, Guangzhou, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp 1, Dept Endocrinol, Div Life Sci & Med, Hefei, Peoples R China
来源：
HEPATOLOGY | 2020年 / 71卷 / 03期
关键词：
BETA-CELL FUNCTION; GLYCEMIC CONTROL;
D O I：
10.1002/hep.30991
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1129 / 1129
页数：1
相关论文
共 50 条
  • [1] Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease
    Taneja, Vikas
    HEPATOLOGY, 2020, 71 (03) : 1128 - 1128
  • [2] Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Yan, Jinhua
    Yao, Bin
    Kuang, Hongyu
    Yang, Xubin
    Huang, Qin
    Hong, Tianpei
    Li, Yushu
    Dou, Jingtao
    Yang, Wenying
    Qin, Guijun
    Yuan, Huijuan
    Xiao, Xinhua
    Luo, Sihui
    Shan, Zhongyan
    Deng, Hongrong
    Tan, Ying
    Xu, Fen
    Xu, Wen
    Zeng, Longyi
    Kang, Zhuang
    Weng, Jianping
    HEPATOLOGY, 2019, 69 (06) : 2414 - 2426
  • [3] Liraglutide, sitagliptin, and insulin glargine added to metformin: The effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Science Foundation in China, 2019, (03) : 32 - 32
  • [4] Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus REPLY
    Weng, Jianping
    HEPATOLOGY, 2019, 69 (05) : 2304 - 2305
  • [5] Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Upala, Sikarin
    HEPATOLOGY, 2019, 69 (05) : 2303 - 2304
  • [6] Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes
    Liu, Lin
    Yan, Hongmei
    Xia, MingFeng
    Zhao, Lin
    Lv, Minzhi
    Zhao, Naiqin
    Rao, Shengxiang
    Yao, Xiuzhong
    Wu, Weiyun
    Pan, Baishen
    Bian, Hua
    Gao, Xin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (05)
  • [7] Nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Cusi, Kenneth
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) : 141 - 149
  • [8] Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases"
    Turan, Yasar
    ANGIOLOGY, 2020, 71 (01) : 88 - 88
  • [9] Hepatotoxicity Associated with Metformin Therapy in Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease
    Cone, Catherine J.
    Bachyrycz, Amy M.
    Murata, Glen H.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (10) : 1655 - 1659
  • [10] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Nar, A.
    Gedik, O.
    ACTA DIABETOLOGICA, 2009, 46 (02) : 113 - 118
12345